Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2023 1
2024 1
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year

Filters applied: . Clear all
Page 1
Case Study: Personalized Oral Low-dose Naltrexone Titration for Pain Management.
Rodriguez F, Carvalho M, Banov F. Rodriguez F, et al. Int J Pharm Compd. 2023 Nov-Dec;27(6):468-473. Int J Pharm Compd. 2023. PMID: 38100664
In the U.S., naltrexone is commercially available as 50-mg tablets, and the adult dosage strength typically ranges between 50 mg once daily and 100 mg once daily. ...Food and Drug Administration recently granted an orphan drug designation for low-dose …
In the U.S., naltrexone is commercially available as 50-mg tablets, and the adult dosage strength typically ranges between 50 …
Effective Doses of Low-Dose Naltrexone for Chronic Pain - An Observational Study.
Marcus NJ, Robbins L, Araki A, Gracely EJ, Theoharides TC. Marcus NJ, et al. J Pain Res. 2024 Mar 21;17:1273-1284. doi: 10.2147/JPR.S451183. eCollection 2024. J Pain Res. 2024. PMID: 38532991 Free PMC article.
CONCLUSION: The maximally effective dose of low-dose naltrexone for the treatment of chronic pain is idiosyncratic, suggesting the need for 1) dosage titration to establish a maximally effective dose and 2) the possibility of re-introduction of low …
CONCLUSION: The maximally effective dose of low-dose naltrexone for the treatment of chronic pain is idiosyncratic, sug …
Extended release naltrexone injection is performed in the majority of opioid dependent patients receiving outpatient induction: a very low dose naltrexone and buprenorphine open label trial.
Mannelli P, Wu LT, Peindl KS, Swartz MS, Woody GE. Mannelli P, et al. Drug Alcohol Depend. 2014 May 1;138:83-8. doi: 10.1016/j.drugalcdep.2014.02.002. Epub 2014 Feb 15. Drug Alcohol Depend. 2014. PMID: 24602363 Free PMC article. Clinical Trial.
Here we present findings from an open label study that tested whether the transition from opioid addiction to XR-NTX can be safely and effectively performed in an outpatient setting using very low dose naltrexone and buprenorphine. METHODS: Twenty treatment s …
Here we present findings from an open label study that tested whether the transition from opioid addiction to XR-NTX can be safely and effec …